1. Braunwald E, Colucci WS (1984) Evaluating the efficacy of new inotropic agents. J Am Coll Cardiol 3: 1570–1574
2. Packer M (1983) Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism. J Am Coll Cardiol 2: 841–852
3. Tominaga M, Yo E, Ogawa H, Yamashita S, Yabuuchi Y, Nakagawa K (1984) Studies on positive inotropic agents I. Synthesis of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone and related compounds. Chem Pharm Bull 32: 2100–2110
4. Yamashita S, Hosokawa T, Kojima M, Mori T, Yabuuchi Y (1984) In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), a novel positive inotropic drug, in various animals. Arzneim Forsch/Drug Research 34: 342–346
5. Taira N, Endoh M, Iijima T, Satoh K, Yanagisawa T, Yamashita S, Maruyama M, Kawada M, Morita T, Wada Y (1984) Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart. Arzneim Forsch/Drug Research 34: 347–354